Jeff Rohacek is a Utica, New York based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. His current practice location is 1213 Court St., Suite 100, Utica. Patients can book an appointment with him at 315-725-0529.
Jeff Rohacek is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. He helps his clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Jeff Rohacek speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Jeff Rohacek
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Male
Credentials:
CASAC
Accepts Medicare Assignment:
No
Practice Address:
1213 Court St., Suite 100, Utica, New York, 13502
Phone:
315-725-0529
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1518470244
NPI Enumeration Date:
16 Nov, 2017
NPI Last Update On:
16 Nov, 2017
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
518 James St, Syracuse, New York
Zip:
13203-2238
Patients can reach Jeff Rohacek at 1213 Court St., Suite 100, Utica, New York or can call to book an appointment on 315-725-0529. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.